Difficulty: Medium
Average Score: 65%
Testbank
A patient with gastroesophageal reflux disease (GERD) has a diagnosis of Barretts esophagus with minor cell changes. Which of the following principles should be integrated into the patients subsequent care?
Correct answer
A
Rationale
A: The patient will require an upper endoscopy every 6 months to detect malignant changes.
Regular upper endoscopies are essential for patients with Barrett's esophagus, especially those with minor cell changes, to monitor for dysplasia and potential progression to esophageal cancer. This surveillance is crucial in managing the risk of malignant transformation associated with Barrett's esophagus.
B: Liver enzymes must be checked regularly, as H2 receptor antagonists may cause hepatic damage. H2 receptor antagonists are generally considered safe and are not commonly associated with significant hepatic damage, making routine liver enzyme monitoring unnecessary in this context.
C: Small amounts of blood are likely to be present in the stools and are not cause for concern. While gastrointestinal bleeding can occur, any presence of blood in the stool should be evaluated promptly in patients with Barrett's esophagus due to the increased risk of malignancy.
D: Antacids may be discontinued when symptoms of heartburn subside. Antacids are often part of long-term management for GERD and Barrett's esophagus, and discontinuation should be based on comprehensive symptom management rather than just symptom resolution.
Regular upper endoscopies are essential for patients with Barrett's esophagus, especially those with minor cell changes, to monitor for dysplasia and potential progression to esophageal cancer. This surveillance is crucial in managing the risk of malignant transformation associated with Barrett's esophagus.
B: Liver enzymes must be checked regularly, as H2 receptor antagonists may cause hepatic damage. H2 receptor antagonists are generally considered safe and are not commonly associated with significant hepatic damage, making routine liver enzyme monitoring unnecessary in this context.
C: Small amounts of blood are likely to be present in the stools and are not cause for concern. While gastrointestinal bleeding can occur, any presence of blood in the stool should be evaluated promptly in patients with Barrett's esophagus due to the increased risk of malignancy.
D: Antacids may be discontinued when symptoms of heartburn subside. Antacids are often part of long-term management for GERD and Barrett's esophagus, and discontinuation should be based on comprehensive symptom management rather than just symptom resolution.